Research programme: leukotriene antagonists - VUFB

Drug Profile

Research programme: leukotriene antagonists - VUFB

Alternative Names: 19354; 20076; 20556; Leukotriene antagonists research programme - VUFB; VUFB 19354; VUFB 20076; VUFB 20556

Latest Information Update: 14 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator VUFB
  • Class Quinolines
  • Mechanism of Action Leukotriene B4 receptor antagonists; Leukotriene D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 29 Sep 2004 Preclinical trials in Asthma in Czech Republic (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top